I agree BL and ER. NP hasn't hid that we need add
Post# of 148325
How they go about this is the question. I'm not confident that the previous 'we have stopped all PIPE and dilutive raises' is not retracted and we see more. My hope is they get the BLA submitted and are able to use the commercial inventory and get a loan to bridge the gap until a deal is complete. I have little doubt a deal will happen, just when and how much funding is needed until then. Regardless of how it is raised, I have no doubt they will be able to get the funding needed, leronlimab will get approved and revenues will be in 1H2020.
I've been looking forward to the end of 2019 all year and other than the TNBC delay, that hasn't changed.